Charles River Laboratories (CRL) earnings · rev $4.02B
These earnings events as JSON? API free 100/dayCharles River Laboratories (CRL) is a diagnostics & research company listed on US.
This CRL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. Revenue was down 0.9% from 2024-12-28 to 2025-12-27. CRL currently screens at market cap $7.78B.
When the next CRL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 0.9% from 2024-12-28 to 2025-12-27. An earnings headline that ignores that move is noise.
Not investment advice. Full CRL research stays on the stock page; the tape stays on the quote page.
CRL earnings FAQ
What are CRL's latest revenue and net income?
Latest cached Charles River Laboratories (CRL) revenue for Dec 27, 2025 was $4.02B. Net income was -$144.3M. Statements: https://lician.com/financials/crl
What is CRL's latest diluted EPS?
Latest cached Charles River Laboratories (CRL) diluted EPS for Dec 27, 2025 was -$2.91.
What period does the latest CRL earnings print cover?
The latest cached Charles River Laboratories (CRL) earnings print covers Dec 27, 2025. The prior cached period on this page is Dec 28, 2024.
How did CRL revenue change from the prior cached period?
Cached Charles River Laboratories (CRL) revenue was down 0.9% from $4.05B (Dec 28, 2024) to $4.02B (Dec 27, 2025). Statements: https://lician.com/financials/crl
Where are CRL earnings listed?
Cached earnings facts for Charles River Laboratories (CRL) are listed at https://lician.com/earnings/crl. Statements: https://lician.com/financials/crl
Not investment advice.